(Click on image to enlarge)

An Israeli company, Stratasys Ltd., saw shares climb after the company raised its earnings outlook for the year and unexpectedly turned an adjusted profit in the third quarter. 

I have waited for a very long time for companies who pioneer 3D printing to begin to turn profits as they have spent massive amounts of money on research and development and have been way less concerned with shareholders’ profits. 

Here is a list of some of the areas 3D printing impacts 

• Aerospace 
• Automotive 
• Consumer Products 
• Dental 
• Medical 
• Education 
• Art and Fashion
• Agriculture 
• Applications
• Manufacturing
• Investment Casting
• Jigs and Fixtures
• Production Parts
• Rapid Prototyping
• Packaging
• Design
• Composite Tooling
• Dentures 

Furthermore, SSYS has become the official 3D Printing Partner of NASCAR, which will now exclusively use Stratasys 3D printing technology for the design and production of parts and tools.  

Today’s range traded inside yesterday’s trading range. 

The price is above the 200-DMA and the July 6-month calendar range high. 

The distance between the 50 and 200-DMAs narrows. 

SSYS outperforms SPY. 

Momentum is improving. 

The risk is clear and the target over current levels brings this to around 13 for now. 

Geoff and I did a podcast yesterday evening-SSYS is featured along with momentum stocks harder to trade right now.  

ETF Summary 

(Pivotal means short-term bullish above that level and bearish below) 

S&P 500 (SPY) 600 pivotal support 

Russell 2000 (IWM) Slow drift below support-a double top would catch a lot of investors off guard 

Dow (DIA) 445 pivotal  

Nasdaq (QQQ) 507 support 

Regional banks (KRE) 65 support 70 resistance 

Semiconductors (SMH) 250 resistance 240 support 

Transportation (IYT) 71.40 the 50-DMA to hold  

Biotechnology (IBB) 140 support 144 resistance  

Retail (XRT) 80 support 87 resistance 

iShares iBoxx Hi Yd Cor Bond ETF (HYG) 79.50 pivotal  

More By This Author:

Long Bonds TLT: Agony And Ecstasy
Turnaround Tuesday: A Look At Emerging Markets
Technical Monday: Novo Nordisk, A Love Story